Psoas muscle size as a frailty measure for open and transcatheter aortic valve replacement
Psoas muscle size as a frailty measure for open and transcatheter aortic valve replacement
复制标题
腰大肌大小作为开放和经导管主动脉瓣置换术的脆弱指标
DOI:
10.1016/j.jtcvs.2015.11.022
复制
发表时间:
2016-03-01
影响因子:
6
通讯作者:
Patel, Himanshu J.
中科院分区:
文献类型:
--
作者:
Paknikar, Raghavendra;Friedman, Jeffrey;Patel, Himanshu J.
Objective: To evaluate the use of sarcopenia as a frailty assessment tool for patients with aortic stenosis undergoing surgical aortic valve replacement (SAVR) or transcatheter aortic valve replacement (TAVR).Methods: The study cohort comprised 295 patients who underwent either SAVR (n = 156) or TAVR (n = 139). The mean preoperative Society of Thoracic Surgeons mortality risk score was 4.7%. Preoperative computed tomography (CT) scans were used to calculate gender-standardized total psoas area (TPA), as a validated measure of sarcopenia.Results: For the entire cohort, independent predictors of a composite measure of 30-day death, stroke, renal failure, prolonged ventilation, and deep wound infection included preoperative STS major morbidity and mortality risk score (odds ratio [OR], 91.1; P = .02) and TPA (OR, 0.5; P = .024). Two-year survival was 85.7% in patients with sarcopenia, compared with 93.8% in patients without sarcopenia (P = .02). Independent predictors of late survival included TPA (hazard ratio, 0.47; P = .02). Male sex (OR, 0.52; P = .04) and TPA (OR, 0.6; P = .001) were predictive of high resource utilization. A separate analysis by treatment group found that TPA predicted high resource utilization after SAVR (OR, 0.4; P